Literature DB >> 15499384

The effect of TNF-alpha on glycosylation pathways in bovine synoviocytes.

Xiaojing Yang1, Michael Lehotay, Tassos Anastassiades, Mark Harrison, Inka Brockhausen.   

Abstract

Synoviocytes are fibroblastic cells that line joint cavities. These cells synthesize numerous cell-surface and extracellular-matrix glycoproteins that are required for maintenance of the joint. Joint inflammation, such as occurs in arthritis, has been shown to have major effects on synoviocyte proliferation and on the biosynthesis of glycoproteins. The structures of the carbohydrate moieties of glycoproteins, however, and the enzymes involved in their synthesis have not yet been described for synoviocytes. Therefore, to characterize the cell-surface glycoconjugates, synoviocytes were isolated from bovine ankles, and the cells were grown in primary cultures. Lectin-binding assays were used to identify exposed N- and O-glycan carbohydrate determinants on synoviocytes, and specific enzyme assays were used to identify some of the glycosyltransferases involved in the synthesis of the glycan chains. A number of the enzymes that synthesize N- and O-linked oligosaccharides were found to be active in cell-free extracts of synoviocytes, including those that synthesize core-1-based O-glycans and the more complex bi-antennary N-glycans. To understand the molecular events underlying the inflammatory response in the synovium of arthritis patients, we examined the effect of the inflammatory cytokine tumour necrosis factor alpha (TNF-alpha) on synoviocytes and on glycosylation profiles. TNF-alpha treatment, which induces apoptosis in synoviocytes, was accompanied by changes in lectin-binding patterns, indicating alterations in the expression of cell-surface oligosaccharides. Concurrently, changes in specific enzyme activities were observed in treated cells. Two enzymes potentially important to the inflammatory process, core 2 beta6-GlcNAc-transferase and beta4-Gal-transferase, increased after TNF-alpha treatment. This is the first study of glycoprotein biosynthesis in synoviocytes, and it shows that synoviocytes have a characteristic glycosylation phenotype that is altered in the presence of inflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15499384     DOI: 10.1139/o04-058

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  15 in total

1.  Role of endothelial N-glycan mannose residues in monocyte recruitment during atherogenesis.

Authors:  David W Scott; Jie Chen; Balu K Chacko; James G Traylor; Anthony W Orr; Rakesh P Patel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-06-21       Impact factor: 8.311

2.  Clinical validation of a link between TNF-alpha and the glycosylation enzyme core 2 GlcNAc-T and the relationship of this link to diabetic retinopathy.

Authors:  B M Ben-Mahmud; W H Chan; R M Abdulahad; A Datti; A Orlacchio; E M Kohner; R Chibber
Journal:  Diabetologia       Date:  2006-07-11       Impact factor: 10.122

3.  Specificity of β1,4-galactosyltransferase inhibition by 2-naphthyl 2-butanamido-2-deoxy-1-thio-β-D-glucopyranoside.

Authors:  Yin Gao; Carmen Lazar; Walter A Szarek; Inka Brockhausen
Journal:  Glycoconj J       Date:  2010-10-26       Impact factor: 2.916

4.  Inflammatory Stress Causes N-Glycan Processing Deficiency in Ocular Autoimmune Disease.

Authors:  Ashley M Woodward; Sylvain Lehoux; Flavio Mantelli; Antonio Di Zazzo; Inka Brockhausen; Stefano Bonini; Pablo Argüeso
Journal:  Am J Pathol       Date:  2018-11-15       Impact factor: 4.307

5.  Endothelial surface N-glycans mediate monocyte adhesion and are targets for anti-inflammatory effects of peroxisome proliferator-activated receptor γ ligands.

Authors:  Balu K Chacko; David W Scott; Robert T Chandler; Rakesh P Patel
Journal:  J Biol Chem       Date:  2011-09-12       Impact factor: 5.157

6.  UDP-Gal: GlcNAc-R beta1,4-galactosyltransferase--a target enzyme for drug design. Acceptor specificity and inhibition of the enzyme.

Authors:  Inka Brockhausen; Melinda Benn; Shridhar Bhat; Sandra Marone; John G Riley; Pedro Montoya-Peleaz; Jason Z Vlahakis; Hans Paulsen; John S Schutzbach; Walter A Szarek
Journal:  Glycoconj J       Date:  2006-11       Impact factor: 2.916

7.  Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells.

Authors:  Yi-Mi Wu; D David Nowack; Gilbert S Omenn; Brian B Haab
Journal:  J Proteome Res       Date:  2009-04       Impact factor: 4.466

8.  Lectin binding patterns reflect the phenotypic status of in vitro chondrocyte models.

Authors:  S Toegel; V E Plattner; S Q Wu; M B Goldring; C Chiari; A Kolb; F M Unger; S Nehrer; F Gabor; H Viernstein; M Wirth
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-03-05       Impact factor: 2.416

9.  Effects of simvastatin, ezetimibe, and their combination on histopathologic alterations caused by adjuvant-induced arthritis.

Authors:  Carmem Patrícia Barbosa; Alessandra Milene Ritter; Lorena Gimenez da Silva; Renata Grespan; Roberto Kenji Nakamura Cuman; Luzmarina Hernandes; Ciomar Aparecida Bersani-Amado
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

10.  Phenotype-related differential alpha-2,6- or alpha-2,3-sialylation of glycoprotein N-glycans in human chondrocytes.

Authors:  S Toegel; M Pabst; S Q Wu; J Grass; M B Goldring; C Chiari; A Kolb; F Altmann; H Viernstein; F M Unger
Journal:  Osteoarthritis Cartilage       Date:  2009-09-22       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.